Which is the best combination therapy in relapsed and refractory multiple myeloma?
How can we overcome ibrutinib resistance?
Brewing T-cell therapies for leukemia and lymphoma
Panel discussion on novel therapies and targets for lymphoma
John Gribben et al.
The challenges associated with managing multiple myeloma patients on immunotherapy
Ignacio Melero Bermejo